Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.

A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.

A systematic review of basic and clinical science research has revealed no definitive standard for detecting military veterans at risk of suicidal behavior, nor is there a clear standard of treatment to prevent suicide among U.S. veterans.

Researchers at OHSU have developed a process to engineer artificial blood vessels which are used to help regenerate teeth, possibly changing the way root canal treatments will be done in the future.